Community Academic Profiles–

Kristen N Ganjoo

Back to Profile

Publication Details

  • A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: a Hoosier Oncology Group Study.

    Ganjoo KN, Gordon MS, Sandler AB, Warner RE, Fife K, Poirier S, Seshadri R, Loehrer PJ. Oncology. 2002; 62 (4): 299-304

    To determine the maximum tolerated dose (MTD) of weekly gemcitabine plus docetaxel, a dose escalation trial of both drugs was developed with each administered weekly for 3 weeks out of 4.

    PubMedID: 12138236

Stanford Medicine Resources:

Footer Links: